The role of vaccines in fighting antimicrobial resistance (AMR)

Area of Science:

• Microbiology
• Immunology
• Public Health

Background:

• Antimicrobial resistance (AMR) is a growing global health threat, leading to increased morbidity and mortality from antibiotic-resistant bacteria.
• The emergence of multidrug-resistant pathogens necessitates urgent action and novel strategies to combat AMR.
• Global action plans, including antimicrobial stewardship and new antibiotic development, are in place, yet vaccines remain an under-recognized tool.

Purpose of the Study:

• To explore the drivers of antibiotic use and the subsequent development of AMR.
• To highlight the established role of existing vaccines in reducing AMR.
• To discuss the future potential of new vaccines in combating AMR and associated challenges.

Main Methods:

• Literature review of AMR trends and vaccine impact.
• Analysis of existing data on vaccine-preventable diseases and antibiotic consumption.
• Exploration of current vaccine development pipelines for AMR reduction.

Main Results:

• Vaccines like Hib and pneumococcal conjugate vaccines have demonstrated success in preventing severe diseases and reducing antibiotic use.
• Existing vaccines contribute significantly to AMR reduction efforts by decreasing the incidence of bacterial infections requiring antibiotic treatment.
• New vaccine candidates show promise for further mitigating AMR by targeting a broader range of resistant pathogens.

Conclusions:

• Vaccines are a critical, yet historically underutilized, strategy in the global fight against antimicrobial resistance.
• Continued investment in and implementation of vaccination programs are essential for reducing antibiotic reliance and combating AMR.
• Addressing challenges in vaccine development and accessibility is crucial for maximizing their impact on global public health.